UAE – Gulf Pharmaceutical Industries (JULPHAR) has appointed Mr. Basel Ziyadeh as the new Chief Executive Officer (CEO) of its manufacturing business.

Julphar is one of the largest pharmaceutical manufacturers in the Middle East and North Africa (MENA) region and one of the leading producers of insulin in the world.

In a press release, Julphar said: “Basel Ziyadeh will succeed Essam Mohamed as CEO, who has stepped down from the senior role after joining in 2020.”

The newly appointed CEO is expected to play a significant role in the organization’s strategy aimed at delivering sustainable growth around six core pillars.

He will be responsible for maximising revenue from Julphar’s current product portfolio, new product launches, and geographical expansion.

In addition, he will oversee strategic business initiatives, advanced specialty products initiatives, and inorganic growth initiatives.

The Emirati pharmaceutical manufacturer has selected Mr. Ziyadeh as the ideal candidate to drive strategic growth and scale its operations in the MENA region and beyond.

With over 25 years of experience in the healthcare sector, he will be leading Julphar to achieve its ambitious goal to deliver greater impact across all the markets the manufacturer serves.

Ziyadeh brings a deep understanding of pharmaceutical marketing and multi-site manufacturing, as well as strategy development in the field of vaccines and biological medicines.

Prior to his current role, Ziyadeh served at renowned pharmaceutical companies such as Hikma Pharmaceuticals and Tabuk Pharmaceuticals.

He served as an advisor and board member for several pharmaceutical entities across Saudi Arabia, Egypt, Jordan, Sudan, Iraq, and Lebanon,” outlined Julphar.

Moreover, Ziyadeh holds a Bachelor’s degree in biological sciences from the University of Jordan in the Middle East and has earned a Master of Business Administration degree from the American University of Beirut in Lebanon.

Commenting on the leadership changes, Sheikh Saqer Humaid Al Qasimi, Chairman of the Board at Julphar, said: “Mr. Basel is a seasoned leader admired for his wealth of experience in the industry working with top global and regional companies across the MENA region.”

He lauded Basel Ziyadeh on his appointment while noting that his proven track record in driving business transformation and expansion with a hands-on approach will further propel Julphar’s mission.

The appointment comes as the company has undergone significant changes in recent years, streamlining its activities by divesting from its non-core activities and focusing on its Strategy 2030.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.